For the very first time, we are uniting leading pharma, pioneering biotechs and reputed academics at the Wnt & β-Catenin Targeted Drug Discovery Summit.
Our top Wnt speakers will share lessons learned to regulate this pathway and exploit untapped therapeutic potentials – bringing novel treatments for patients from oncology to autoimmune to regenerative medicine. As the world sees growing financial ROI in the Wnt pathway, with huge investments and progress by the industry, this is the time for you to attend this cutting-edge conference
5 unmissable keynotes include:
Supercharging Your Wnt/β-catenin Clinical Program by Surrozen, Iterion Therapeutics, AntlarA & Leap Therapeutics
Getting a Grip on Wnt Biology to Theorize the Latest Opportunities & Understandings with Iterion Therapeutics, Genentech & Auburn University
Opportunities to Aid Drug Discovery & Further Research Efforts with Biovista & the DTRF
Delving into Immuno-Oncology to Further Oncological Treatment Efficacy, brought to you by UAB, Duke Cancer Institute & Shandong First Medical University
Harnessing Novel Pathways Approach to Drive Preclinical Insights delivered by
Fog Pharma, RedX Pharma & The University of Oxford
What to Expect?
- Learn from 24+ thought leaders in our speaker faculty
- Access 12+ hours of content exploring the latest advances in the Wnt/β-catenin pathway
- Discuss during live speaker Q&As and breakout audience chats
- Form connections in our multiple and varied hybrid networking sessions